BlackRock’s Petros Pharmaceuticals PTPI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-645
| Closed | -$1.11K | – | 5483 |
|
2025
Q1 | $1.11K | Hold |
645
| – | – | ﹤0.01% | 5285 |
|
2024
Q4 | $6.35K | Hold |
645
| – | – | ﹤0.01% | 5151 |
|
2024
Q3 | $5.76K | Sell |
645
-15
| -2% | -$134 | ﹤0.01% | 4983 |
|
2024
Q2 | $7.55K | Hold |
660
| – | – | ﹤0.01% | 5041 |
|
2024
Q1 | $24.4K | Sell |
660
-4
| -0.6% | -$148 | ﹤0.01% | 4939 |
|
2023
Q4 | $23.4K | Buy |
664
+4
| +0.6% | +$141 | ﹤0.01% | 4994 |
|
2023
Q3 | $28.6K | Hold |
660
| – | – | ﹤0.01% | 5024 |
|
2023
Q2 | $33.5K | Hold |
660
| – | – | ﹤0.01% | 5047 |
|
2023
Q1 | $23K | Hold |
660
| – | – | ﹤0.01% | 5152 |
|
2022
Q4 | $38.5K | Hold |
660
| – | – | ﹤0.01% | 5190 |
|
2022
Q3 | $84K | Hold |
660
| – | – | ﹤0.01% | 5135 |
|
2022
Q2 | $139K | Sell |
660
-107
| -14% | -$22.5K | ﹤0.01% | 5047 |
|
2022
Q1 | $300K | Buy |
767
+689
| +883% | +$269K | ﹤0.01% | 4928 |
|
2021
Q4 | $65K | Buy |
78
+4
| +5% | +$3.33K | ﹤0.01% | 5293 |
|
2021
Q3 | $38K | Sell |
74
-2
| -3% | -$1.03K | ﹤0.01% | 5250 |
|
2021
Q2 | $59K | Buy |
76
+3
| +4% | +$2.33K | ﹤0.01% | 5089 |
|
2021
Q1 | $68K | Buy |
73
+19
| +35% | +$17.7K | ﹤0.01% | 4819 |
|
2020
Q4 | $59K | Buy |
+54
| New | +$59K | ﹤0.01% | 4572 |
|